Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.34 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24343 | 0.76 | LMNA (0.62) | TDP1ALDH1A1TSHRNPC1RAB9A | |
| SCHEMBL24395 | 0.75 | CLK1 (0.46) | KDM4E | |
| SCHEMBL524536 | 0.73 | CYP3A4 (0.52) | CYP2A6TDP1ALDH1A1HSD17B10TSHR | |
| SCHEMBL67041 | 0.73 | CCR1 (0.64) | TDP1ALDH1A1HSD17B10TSHRHIF1A | |
| SCHEMBL2519552 | 0.73 | KDM4E (0.50) | TDP1ALDH1A1HSD17B10NPC1RAB9A | |
| SCHEMBL2519517 | 0.73 | KDM4E (0.50) | CYP1A2LMNAKDM4E | |
| SCHEMBL2142947 | 0.73 | MAPT (0.38) | ALDH1A1HPRT1HIF1AMAPTL3MBTL1 | |
| SCHEMBL2304470 | 0.71 | METAP2 (0.38) | CYP2A6ALDH1A1RAB9ALMNA | |
| SCHEMBL1828724 | 0.71 | CYP1A2 (0.37) | CYP2A6TDP1ALDH1A1NPC1RAB9A | |
| SCHEMBL144188 | 0.71 | METAP2 (0.52) | TDP1ALDH1A1HSD17B10TSHRNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118324788-A | Organic electroluminescent compound and application thereof | 宁波卢米蓝新材料有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-118239966-A | Organic electroluminescent compound and application thereof | 宁波卢米蓝新材料有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-118102761-A | Light emitting device, manufacturing method thereof and display panel | 北京维信诺科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-118076128-A | Light emitting device, manufacturing method thereof and display panel | 北京维信诺科技有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-118026880-A | Aryl amide compound, pharmaceutical composition containing same and application thereof | 华东师范大学 | 2024-05-14 | — | — | CN | claimed |
| CN-118027085-A | Organic electroluminescent compound and application thereof | 宁波卢米蓝新材料有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-117794343-A | Composite material, preparation method thereof, photoelectric device and display device | TCL科技集团股份有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-117551107-A | Condensed ring organic compound and preparation method and application thereof | 华南理工大学 | 2024-02-13 | — | — | CN | claimed |
| WO-2024012365-A1 | ORGANIC COMPOUND AND USE THEREOF | 清华大学 | 2024-01-18 | — | — | WO | claimed |
| CN-117143128-A | Organic compound based on phenol oxygen-boron nitrogen structure and application thereof | 浙江虹舞科技有限公司 | 2023-12-01 | — | — | CN | claimed |
| US-8557953-B2 | Polymers comprising substituted anthracenyl units, blends comprising these polymers, and devices comprising these polymers or blends | MERCK PATENT GMBH (DE) | 2013-10-15 | — | — | US | claimed |
| US-20130126855-A1 | POLYMERS CONTAINING SUBSTITUTED BENZODITHIOPHENE UNITS, BLENDS COMPRISING THESE POLYMERS, AND DEVICES COMPRISING THESE POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2013-05-23 | — | — | US | claimed |
| US-20120108731-A1 | POLYMERS COMPRISING SUBSTITUTED ANTHRACENYL UNITS, BLENDS COMPRISING THESE POLYMERS, AND DEVICES COMPRISING THESE POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2012-05-03 | — | — | US | claimed |
| WO-2012013310-A1 | POLYMERS CONTAINING SUBSTITUTED BENZODITHIOPHENE UNITS, BLENDS CONTAINING SAID POLYMERS, AND DEVICES CONTAINING SAID POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2012-02-02 | — | — | WO | claimed |
| US-8034941-B2 | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-10-11 | — | — | US | claimed |
| WO-2010149258-A1 | POLYMERS COMPRISING SUBSTITUTED ANTHRACENYL UNITS, BLENDS COMPRISING SAID POLYMERS, AND DEVICE COMPRISING SAID POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2010-12-29 | — | — | WO | claimed |
| US-20090258856-A1 | IMIDAZOPYRIDAZINONE AND IMIDAZOPYRIDONE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-10-15 | — | — | US | claimed |
| US-7566707-B2 | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-07-28 | — | — | US | claimed |
| EP-1641799-B1 | IMIDAZO-PYRIDAZINONE DERIVATIVES AND IMIDAZO-PYRIDONE DERIVATIVES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM INT (DE) | 2008-03-12 | — | — | EP | claimed |
| US-20050026921-A1 | New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090258856-A1 | IMIDAZOPYRIDAZINONE AND IMIDAZOPYRIDONE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS | DPP4, DPP3, DPP7 | CYP2A6 73/4885TDP1 727/4885ALDH1A1 213/4885 |
| US-20050026921-A1 | New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | DPP4, DPP3, DPP7 | CYP2A6 73/4885TDP1 616/4885ALDH1A1 239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.